Both This medication and the drug represent new strategies to managing type 2 diabetes, and increasingly, obesity. Semaglutide is a twin receptor activator that targets several hormones involved in blood sugar control: https://thingstoknowabouttirzepa095500.dm-blog.com/43622664/understanding-tirzepatide-and-mounjaro-the-thorough-explanation